flutamide has been researched along with Arrhythmia in 1 studies
Flutamide: An antiandrogen with about the same potency as cyproterone in rodent and canine species.
Excerpt | Relevance | Reference |
---|---|---|
"Elevated risks of arrhythmia (adjusted HR=1." | 1.46 | Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study. ( Cassidy-Bushrow, AE; Haque, R; Keating, NL; Potosky, AL; Tsai, HT; UlcickasYood, M; Van Den Eeden, SK; Xu, X, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haque, R | 1 |
UlcickasYood, M | 1 |
Xu, X | 1 |
Cassidy-Bushrow, AE | 1 |
Tsai, HT | 1 |
Keating, NL | 1 |
Van Den Eeden, SK | 1 |
Potosky, AL | 1 |
1 other study available for flutamide and Arrhythmia
Article | Year |
---|---|
Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study.
Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Arrhythmias, Cardiac; Califor | 2017 |